A study reported that EZH2 was highly expressed in NSCLC tissues and cells, and EZH2 overexpression inhibited the apoptosis of NSCLC cells via an increased expression of Bcl-2 and reduced levels of Bax and cleaved caspase-3. The gene discussed is CASP3; the disease is non-small cell lung carcinoma.